Ford's $13 Mil. Annual Prilosec Spend Partly Due To DTC Ads, Exec Says
Executive Summary
Over-prescribing of AstraZeneca's proton pump inhibitor Prilosec to Ford Motor Company health beneficiaries can be partly attributed to direct-to-consumer advertising, Ford Motor Company Health Care Management Director Woodrow Myers, MD, maintained at a health care conference sponsored by the Wall Street Journal May 5 in Washington, D.C.
You may also be interested in...
OTC Coverage Under Rx Plans May Help Restrain Drug Costs - Ford Exec
Expanding drug coverage to include OTCs may merit consideration as a means to restrain growth in pharmacy budgets, Ford Healthcare Management Director Woodrow Myers, MD, suggested.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011